We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Artventive Medical Group Inc (CE) | USOTC:AVTD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.01 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 17, 2016
ARTVENTIVE MEDICAL GROUP, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Nevada |
333-144226 |
26-0148468 |
State or other jurisdiction of incorporation |
Commission File Number |
IRS Identification No. |
2766 Gateway Rd.
Carlsbad, CA 92009
(Address of principal executive offices and Zip Code)
Registrants telephone number, including area code: (760) 471-7700
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On May 17, 2016, Tom Brauser was appointed as a member of the Board of Directors, effective June 1, 2016. Following is a brief description of Mr. Brausers business experience for the past five years:
Mr. Bauser has over 25 years experience in leadership positions for a variety of industries. Since 2014, Mr. Brauser has served as director of special projects for Jones Lang LaSalle. Currently, he is a part-time consultant on a variety of projects assisting clients solve business problems, coordinate logistics and establish effective communications. Between 2012 and 2014, Mr. Brauser served as Chief Operating Officer for BuiltSpace Technologies, Inc. From 2010 to 2011, he served as Vice President of Planning and Financial Control for Intact Financial Corporation (formerly known as AXA Pacific Insurance). He served as Vice President of Operations (Corporate Finance) for Intrawest ULC from 2007 to 2009, and as its Vice President of Sales and Operations from 2005 through 2007.
There are no family relationships between Mr. Brauser and any member of the Board of Directors or any other officer of the Company. There have been no transactions since the beginning of the Companys last fiscal year, or any proposed transaction, in which the Company was or is to be party and in which Mr. Brauser had or will have a direct or indirect material interest.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
ARTVENTIVE MEDICAL GROUP, INC. |
|
|
/s/ Leon Rukakov |
|
Dated: May _23, 2016 |
By: |
Leon Rudakov |
|
Its |
President |
|
|
|
1 Year Artventive Medical (CE) Chart |
1 Month Artventive Medical (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions